0

530991

ROOPAIND

img img img img
No Data Available

ROOPA INDUSTRIES LTD. Share Price Update

As of the latest trading session, ROOPA INDUSTRIES LTD. share price is currently at ₹43.2, which is up by ₹1.35 from its previous closing. Today, the stock has fluctuated between ₹43.20 and ₹43.20. Over the past year, ROOPA INDUSTRIES LTD. has achieved a return of -23.67%. In the last month alone, the return has been 4.22%.

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ROOPA INDUSTRIES LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    32.90

  • P/E Ratio (TTM)

    19.07

  • Beta

    0.56

  • Book Value / share

    23.19

  • Return on equity

    12.31%

  • EPS (TTM)

    2.46

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.77

info icon alternate text

ROOPA INDUSTRIES LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 33.54
Operating Expense 32.49
Net Profit 0.77
Net Profit Margin (%) 2.29
Earnings Per Share (EPS) 0.98
EBITDA 2.03
Effective Tax Rate (%) 26.66
Particulars SEP 2025 (Values in Cr)
Revenue 28.74
Operating Expense 28.13
Net Profit 0.46
Net Profit Margin (%) 1.60
Earnings Per Share (EPS) 0.59
EBITDA 1.64
Effective Tax Rate (%) 24.19
Particulars JUN 2025 (Values in Cr)
Revenue 35.07
Operating Expense 34.73
Net Profit 0.28
Net Profit Margin (%) 0.79
Earnings Per Share (EPS) 0.36
EBITDA 1.43
Effective Tax Rate (%) 21.62
Particulars MAR 2025 (Values in Cr)
Revenue 29.83
Operating Expense 30.24
Net Profit 0.42
Net Profit Margin (%) 1.40
Earnings Per Share (EPS) 0.51
EBITDA 1.58
Effective Tax Rate (%) 43.24
Particulars DEC 2024 (Values in Cr)
Revenue 30.73
Operating Expense 30.69
Net Profit 0.76
Net Profit Margin (%) 2.47
Earnings Per Share (EPS) 0.97
EBITDA 1.89
Effective Tax Rate (%) 20.83
Particulars MAR 2025 (Values in Cr)
Revenue 120.69
Operating Expense 120.26
Net Profit 2.03
Net Profit Margin (%) 1.68
Earnings Per Share (EPS) 2.57
EBITDA 6.40
Effective Tax Rate (%) 25.36
Particulars MAR 2024 (Values in Cr)
Revenue 70.43
Operating Expense 69.38
Net Profit 1.52
Net Profit Margin (%) 2.15
Earnings Per Share (EPS) 1.95
EBITDA 5.67
Effective Tax Rate (%) 29.95
Particulars MAR 2023 (Values in Cr)
Revenue 76.17
Operating Expense 75.00
Net Profit 1.35
Net Profit Margin (%) 1.77
Earnings Per Share (EPS) 1.73
EBITDA 4.89
Effective Tax Rate (%) 25.41
Particulars MAR 2022 (Values in Cr)
Revenue 46.74
Operating Expense 49.90
Net Profit 1.02
Net Profit Margin (%) 2.18
Earnings Per Share (EPS) 1.30
EBITDA 3.55
Effective Tax Rate (%) 25.73
Particulars MAR 2021 (Values in Cr)
Revenue 26.58
Operating Expense 27.76
Net Profit 0.72
Net Profit Margin (%) 2.70
Earnings Per Share (EPS) 0.98
EBITDA 2.79
Effective Tax Rate (%) 23.65
Particulars MAR 2025 (Values in Cr)
Book Value / Share 22.24
ROE % 12.31
ROCE % 11.93
Total Debt to Total Equity 1.79
EBITDA Margin 5.31
Particulars MAR 2024 (Values in Cr)
Book Value / Share 19.67
ROE % 10.33
ROCE % 12.51
Total Debt to Total Equity 1.52
EBITDA Margin 7.91
Particulars MAR 2023 (Values in Cr)
Book Value / Share 17.73
ROE % 10.17
ROCE % 12.53
Total Debt to Total Equity 1.16
EBITDA Margin 5.96
Particulars MAR 2022 (Values in Cr)
Book Value / Share 16.00
ROE % 8.44
ROCE % 10.23
Total Debt to Total Equity 1.05
EBITDA Margin 6.83
Particulars MAR 2021 (Values in Cr)
Book Value / Share 14.70
ROE % 6.44
ROCE % 7.97
Total Debt to Total Equity 1.21
EBITDA Margin 9.79
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 4.62
Total Assets 76.45
Total Liabilities 76.45
Total Equity 17.49
Share Outstanding 0
Price to Book Ratio 2.30
Return on Assets (%) 2.66
Return on Capital (%) 4.01
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 4.14
Total Assets 64.67
Total Liabilities 64.67
Total Equity 15.47
Share Outstanding 0
Price to Book Ratio 3.01
Return on Assets (%) 2.34
Return on Capital (%) 3.69
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.73
Total Assets 56.54
Total Liabilities 56.54
Total Equity 13.94
Share Outstanding 0
Price to Book Ratio 2.31
Return on Assets (%) 2.38
Return on Capital (%) 4.11
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.01
Total Assets 49.02
Total Liabilities 49.02
Total Equity 12.58
Share Outstanding 0
Price to Book Ratio 1.56
Return on Assets (%) 2.07
Return on Capital (%) 4.13
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.99
Total Assets 46.33
Total Liabilities 46.33
Total Equity 11.56
Share Outstanding 0
Price to Book Ratio 0.64
Return on Assets (%) 1.54
Return on Capital (%) 2.98
Particulars MAR 2025 (Values in Cr)
Net Income 2.72
Cash from Operations -5.90
Cash from Investing 2.17
Cash from Financing 4.81
Net change in Cash 0.40
Free Cash Flow -5.05
Particulars MAR 2024 (Values in Cr)
Net Income 2.17
Cash from Operations 2.66
Cash from Investing 1.11
Cash from Financing -2.09
Net change in Cash 1.03
Free Cash Flow 3.45
Particulars MAR 2023 (Values in Cr)
Net Income 1.80
Cash from Operations 0.09
Cash from Investing -0.98
Cash from Financing 1.81
Net change in Cash 0.45
Free Cash Flow 1.46
Particulars MAR 2022 (Values in Cr)
Net Income 1.36
Cash from Operations 2.68
Cash from Investing 3.65
Cash from Financing -5.00
Net change in Cash 0.99
Free Cash Flow 3.53
Particulars MAR 2021 (Values in Cr)
Net Income 0.93
Cash from Operations -0.29
Cash from Investing 1.33
Cash from Financing -0.57
Net change in Cash 0.24
Free Cash Flow 0.44
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 25.28 10.94 1.31 193.73 23.12 / 42.05
BLISS GVS PHARMA LTD 213.80 20.44 1.99 2261.77 105.05 / 244.05
CIPLA LTD 1351.85 22.97 3.31 109199.83 1283.00 / 1672.20
FERMENTA BIOTECH LIMITED 319.00 10.61 2.40 938.85 220.00 / 399.00
GLAXOSMITHKLINE PHARMA LT 2535.90 42.71 25.15 42959.68 2220.00 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 25.28 24.31 3.52 193.73 23.12 / 42.05
AMRUTAJAN HEALTH LTD 580.45 29.02 4.90 1678.12 548.05 / 789.95
ASTRAZENECA PHARMA IND LT 8798.15 105.73 27.52 21995.38 6501.60 / 10653.05
BLISS GVS PHARMA LTD 213.80 29.13 2.04 2261.77 105.05 / 244.05

ROOPA INDUSTRIES LTD. shareholding pattern

Holding

51.71%
48.02%
0.25%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

ROOPA INDUSTRIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
41.85 -10.76 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 45.70
  • 26 Days 46.20
  • 10 Days 45.80
  • 50 Days 46.60
  • 12 Days 45.90
  • 100 Days 48.40
  • 20 Days 46.10
  • 200 Days 51.80
46.77 PIVOT

First Support

44.63

First Resistance

49.03

Second Support

42.37

Second Resistance

51.17

Third Support

40.23

Third Resistance

53.43

RSI

52.43

ADX

34.19

MACD

-0.30

Williams % R

-38.46

Commodity Channel Index (CCI)

-15.09

Date

2026-03-02

Week

877.00

Same Day

220.00

Month

845.00

1 Year

0.57

3 Year

0.46

Over 1 Month

4.22%

down

Over 1 Year

-23.67%

down

Over 3 Months

0.75%

down

Over 3 Years

-2.04%

down

Over 6 Months

-11.39%

down

Over 5 Years

37.47%

down

ROOPA INDUSTRIES LTD. Corporate Actions

Top Gainers

ROOPA INDUSTRIES LTD. Share Price

Roopa Industries Limited is a part of the TGV Group, a reputed conglomerate in India, which manufactures and exports Chloro Alkali Products, Castor Oil Derivatives, Fatty Acids and Water Treatment Chemicals to various countries. The Company was incorporated in 1985 and operates into manufacturing and marketing of bulk drugs and intermediaries. The Company became a manufacturer of Neutraceuticals, Fine chemicals, Drug Intermediates and Bulk Drugs since 1998. Over the years, it has been a principal supplier to many companies in various countries.

The Company handled critical and risky processes and have dependable technical expertise for carrying out any labyrinthine hazardous manufacturing operations. It offers triphenyl phosphine for use as wittig reagent in the manufacture of pharmaceuticals and cosmetics; as catalyst in hydroformylation, isomerisation, and polymerisation of olefins; as catalysing and curing agent in a range of polymerization reactions, epoxy resins, and photopolymers; and as reducing and deoxygenating agent in quinones, epoxides, amine oxides, and sulfoxides.

The Company produces Active Pharmaceutical Ingredients such as Fluconazole, Sildenafil Citrate, Losartan Potassium and Triphenyl Phosphine (which goes into the production of Cephalosporins, Statins etc.,) and Nutraceuticals such as Glucosamine salts. Triphenyl Phosphine is a product used by the manufacturers of Cephalosporin group of Antibiotics, Statins etc,. There are more usages of Triphenyl Phosphine in areas like specialty resins/paints, fire retardants, Phosphonium salts, phase transfer catalysts, products relating to Agriculture etc., and it has wide range of applications in organic synthesis. Glucosamine is a sheet anchor product, which is a nutraceutical / nutritional supplement. Glucosamine is extracted from a natural resource and has a growing therapeutic usage that helps in Arthritis condition.

The Company apart from this, provides liquid bromine and 1 bromo 3 chloro propane. In addition, it offers glucosamine HCl, glucosamine sulphate sodium chloride, and glucosamine sulphate potassium chloride for use in pharmaceuticals, cosmetics, and nutrition products. It exports products to Germany, the Netherlands, and Sri Lanka.

Parent organization Sree Rayalseema
NSE symbol [-]
Founded 1985
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Roopa Industries Ltd?

Answer Field

Roopa Industries Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 41.85 as on Mar 05 2026 09:07 AM.

What is the Market Cap of Roopa Industries Ltd Share?

Answer Field

The market cap of Roopa Industries Ltd for NSE ₹ 0.00 & for BSE ₹ 32.90 as on Mar 05 2026 09:07 AM.

What is the 52 Week High and Low of Roopa Industries Ltd?

Answer Field

The 52 Week High and Low of Roopa Industries Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 71.99 and ₹ 41.00.

What is 1 year return for Roopa Industries Ltd?

Answer Field

The 1 year returns on the stock has been -23.67%.

What is the P/E Ratio of Roopa Industries Ltd Share?

Answer Field

As on Mar 05 2026 09:07 AM the price-to-earnings (PE) ratio for Roopa Industries Ltd share is 19.07.

What is the PB ratio of Roopa Industries Ltd Share?

Answer Field

As on Mar 05 2026 09:07 AM, the price-to-book (PB) ratio for Roopa Industries Ltd share is 23.19.

How to Buy Roopa Industries Ltd Share?

Answer Field

You can trade in Roopa Industries Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Roopa Industries Ltd Share on Bajaj Broking App?

Answer Field

To buy Roopa Industries Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Roopa Industries Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59